loadpatents
name:-0.038511991500854
name:-0.031543016433716
name:-0.0093321800231934
TEMPEST; Paul Patent Filings

TEMPEST; Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for TEMPEST; Paul.The latest application filed is for "compounds for degrading alpha-synuclein aggregates and uses thereof".

Company Profile
11.34.43
  • TEMPEST; Paul - Taipei TW
  • Tempest; Paul - Shanghai CN
  • Tempest; Paul - Taipei City TW
  • TEMPEST; Paul - Rahway NJ CN
  • Tempest; Paul - Brookline MA US
  • Tempest; Paul - Boston MA US
  • Tempest; Paul - London GB
  • Tempest, Paul - Somerville MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds For Degrading Alpha-synuclein Aggregates And Uses Thereof
App 20220280650 - JANG; Ming-Kuei ;   et al.
2022-09-08
Compounds For Degrading Tau Protein Aggregates And Uses Thereof
App 20220267316 - TEMPEST; Paul ;   et al.
2022-08-25
Compounds for degrading .alpha.-synuclein aggregates and uses thereof
Grant 11,291,732 - Jang , et al. April 5, 2
2022-04-05
Heteroaryl Compounds And Uses Thereof
App 20210253569 - JANG; Ming-Kuei ;   et al.
2021-08-19
2,2-difluorodioxolo A.sub.2A receptor antagonists
Grant 11,046,714 - Amjad , et al. June 29, 2
2021-06-29
N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use
Grant 10,961,215 - Rudd , et al. March 30, 2
2021-03-30
Pyrazole compounds as modulators of FSHR and uses thereof
Grant 10,941,152 - Yu , et al. March 9, 2
2021-03-09
Piperidine derivatives as liver X receptor beta agonists, compositions, and their use
Grant 10,894,775 - Rudd , et al. January 19, 2
2021-01-19
Substituted aminoquinazoline compounds as A.sub.2A antagonist
Grant 10,822,338 - Ali , et al. November 3, 2
2020-11-03
Aryl And Heteroaryl Ether Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use
App 20200247754 - Kind Code
2020-08-06
N-aryl And N-heteroaryl Piperidine Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use
App 20200039951 - Rudd; Michael T. ;   et al.
2020-02-06
Piperidine Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use
App 20190375716 - Rudd; Michael T. ;   et al.
2019-12-12
Pyrazole Compounds As Modulators Of Fshr And Uses Thereof
App 20190135823 - Yu; Henry ;   et al.
2019-05-09
Pyrazole compounds as modulators of FSHR and uses thereof
Grant 10,208,055 - Yu , et al. Feb
2019-02-19
Substituted Aminoquinazoline Compounds As A2a Antagonist
App 20180362530 - Ali; Amjad ;   et al.
2018-12-20
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
Grant 10,011,615 - Ali , et al. July 3, 2
2018-07-03
Pyrazole Compounds As Modulators Of Fshr And Uses Thereof
App 20170253605 - Yu; Henry ;   et al.
2017-09-07
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20170197991 - Ali; Amjad ;   et al.
2017-07-13
Compounds inhibiting leucine-rich repeat kinase enzyme activity
Grant 9,688,654 - Miller , et al. June 27, 2
2017-06-27
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A.sub.2A antagonist properties
Grant 9,676,780 - Ali , et al. June 13, 2
2017-06-13
Compounds inhibiting leucine-rich repeat kinase enzyme activity
Grant 9,493,440 - Miller , et al. November 15, 2
2016-11-15
Compounds inhibiting leucine-rich repeat kinase enzyme activity
Grant 9,416,126 - Miller , et al. August 16, 2
2016-08-16
2,2-difluorodioxolo A2a Receptor Antagonists
App 20160214997 - Amjad; Ali ;   et al.
2016-07-28
Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20160194330 - Ali; Amjad ;   et al.
2016-07-07
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity
App 20160009696 - Miller; Michael ;   et al.
2016-01-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity
App 20160009689 - Miller; Michael ;   et al.
2016-01-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity
App 20160009681 - Miller; Michael ;   et al.
2016-01-14
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20150361098 - Ali; Amjad ;   et al.
2015-12-17
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
Grant 9,096,559 - Harrington , et al. August 4, 2
2015-08-04
Cyclobutyl sulfones as notch sparing gamma secretase inhibitors
Grant 8,759,579 - Heidebrecht , et al. June 24, 2
2014-06-24
Spirocyclic compounds
Grant 8,686,020 - Hamblett , et al. April 1, 2
2014-04-01
Protein kinase modulators and method of use
Grant 8,476,434 - Geuns-Meyer , et al. July 2, 2
2013-07-02
4-carboxybenzylamino Derivatives As Histone Deacetylase Inhibitors
App 20130137690 - Harrington; Paul ;   et al.
2013-05-30
Spirocyclic Compounds
App 20130131041 - Berk; Scott C. ;   et al.
2013-05-23
Inhibitors Of Akt Activity
App 20130102605 - Liang; Peng ;   et al.
2013-04-25
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
Grant 8,389,553 - Harrington , et al. March 5, 2
2013-03-05
Inhibitors of janus kinases
Grant 8,367,706 - Altman , et al. February 5, 2
2013-02-05
Spirocyclic compounds
Grant 8,349,825 - Mampreian , et al. January 8, 2
2013-01-08
Modified malonate derivatives
Grant 8,158,825 - Grimm , et al. April 17, 2
2012-04-17
Aryl-fused spirocyclic compounds
Grant 8,119,652 - Hamblett , et al. February 21, 2
2012-02-21
Histone deacetylase inhibitors with aryl-pyrazolyl-motifs
Grant 8,026,260 - Close , et al. September 27, 2
2011-09-27
Protein Kinase Modulators And Method Of Use
App 20110201602 - GEUNS-MEYER; Stephanie D. ;   et al.
2011-08-18
Movement Animation Method And Apparatus
App 20110119332 - Marshall; Steve ;   et al.
2011-05-19
Spirocyclic Compounds
App 20110098268 - Mampreian; Dawn M. ;   et al.
2011-04-28
Cyclobutyl Sulfones As Notch Sparing Gamma Secretase Inhibitors
App 20110039925 - Heidebrecht; Richard W. ;   et al.
2011-02-17
4-carboxybenzylamino Derivatives As Histone Deacetylase Inhibitors
App 20100324046 - Harrington; Paul ;   et al.
2010-12-23
Spirocyclic compounds
Grant 7,834,026 - Berk , et al. November 16, 2
2010-11-16
Inhibitors Of Janus Kinases
App 20100256097 - Altman; Michael ;   et al.
2010-10-07
N-hydroxy-naphthalene Dicarboxamide And N-hydroxy-biphenyl-dicarboxamide Compounds As Histone Deacetylase Inhibitors
App 20100216796 - Kattar; Solomon ;   et al.
2010-08-26
Inhibitors of janus kinases
Grant 7,763,634 - Young , et al. July 27, 2
2010-07-27
Modified Malonate Derivatives
App 20100160327 - Grimm; Jonathan ;   et al.
2010-06-24
Melanin concentrating hormone receptor antagonist
Grant 7,659,276 - Hulme , et al. February 9, 2
2010-02-09
Inhibitors of Janus Kinases
App 20090306071 - Young; Jonathan R. ;   et al.
2009-12-10
Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs
App 20090291965 - Close; Joshua ;   et al.
2009-11-26
Aryl-Fused Spirocyclic Compounds
App 20090239849 - Hamblett; Christopher ;   et al.
2009-09-24
Spirocyclic Compounds
App 20090209566 - Berk; Scott C. ;   et al.
2009-08-20
Spirocyclic compounds
Grant 7,544,695 - Berk , et al. June 9, 2
2009-06-09
Melanin Concentrating Hormone Receptor Antagonist
App 20090143405 - Hulme; Christopher ;   et al.
2009-06-04
Spirocyclic compounds
App 20070117824 - Berk; Scott C. ;   et al.
2007-05-24
Melanin concentrating hormone receptor antagonist
App 20050215526 - Hulme, Christopher ;   et al.
2005-09-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed